Not logged in Share Save
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target (vol 132, e157101, 2022) Le, Quy; Hadland, Brandon; Smith, Jenny L.; Leonti, Amanda; Huang, Benjamin J.; Ries, Rhonda; Hylkema, Tiffany A.; Castro, Sommer; Tang, Thao T.; Mckay, Cyd N.; Perkins, Lakeisha; Pardo, Laura; Sarthy, Jay; Beckman, Amy K.; Williams, Robin; Idemmili, Rhonda; Furlan, Scott; Ishida, Takashi; Call, Lindsey; Srivastava, Shivani; Loeb, Anisha M.; Milano, Filippo; Imren, Suzan; Morris, Shelli M.; Pakiam, Fiona; Olson, Jim M.; Loken, Michael R.; Brodersen, Lisa; Riddell, Stanley R.; Tarlock, Katherine; Bernstein, Irwin D.; Loeb, Keith R.; Meshinchi, Soheil Share Save
A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models Stabach, Paul R.; Sims, Dominique; Gomez-Banuelos, Eduardo; Zehentmeier, Sandra; Dammen-Brower, Kris; Bernhisel, Andrew; Kujawski, Sophia; Lopez, Sam G.; Petri, Michelle; Goldman, Daniel W.; Lester, Ethan R.; Le, Quan; Ishaq, Tayyaba; Kim, Hana; Srivastava, Shivani; Kumar, Deepika; Pereira, Joao P.; Yarema, Kevin J.; Koumpouras, Fotios; Andrade, Felipe; Braddock, Demetrios T. Share Save
Share Save
Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function Leung, Isabel; Templeton, Megan L.; Lo, Yun; Rajan, Anusha; Stull, Sylvia M.; Garrison, Sarah M.; Salter, Alexander I.; Smythe, Kimberly S.; Correnti, Colin E.; Srivastava, Shivani; Yeung, Cecilia C. S.; Riddell, Stanley R. Share Save
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy Bhatia, Vipul; Kamat, Nikhil V.; Pariva, Tiffany E.; Wu, Li-Ting; Tsao, Annabelle; Sasaki, Koichi; Sun, Huiyun; Javier, Gerardo; Nutt, Sam; Coleman, Ilsa; Hitchcock, Lauren; Zhang, Ailin; Rudoy, Dmytro; Gulati, Roman; Patel, Radhika A.; Roudier, Martine P.; True, Lawrence D.; Srivastava, Shivani; Morrissey, Colm M.; Haffner, Michael C.; Nelson, Peter S.; Priceman, Saul J.; Ishihara, Jun; Lee, John K. Share Save
Share Save
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target Le, Quy; Hadland, Brandon; Smith, Jenny L.; Leonti, Amanda; Huang, Benjamin J.; Ries, Rhonda; Hylkema, Tiffany A.; Castro, Sommer; Tang, Thao T.; McKay, Cyd N.; Perkins, LaKeisha; Pardo, Laura; Sarthy, Jay; Beckman, Amy K.; Williams, Robin; Idemmili, Rhonda; Furlan, Scott; Ishida, Takashi; Call, Lindsey; Srivastava, Shivani; Loeb, Anisha M.; Milano, Filippo; Imren, Suzan; Morris, Shelli M.; Pakiam, Fiona; Olson, Jim M.; Loken, Michael R.; Brodersen, Lisa; Riddell, Stanley R.; Tarlock, Katherine; Bernstein, Irwin D.; Loeb, Keith R.; Meshinchi, Soheil Share Save
Share Save
A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells Veatch, Joshua R.; Singhi, Naina; Srivastava, Shivani; Szeto, Julia L.; Jesernig, Brenda; Stull, Sylvia M.; Fitzgibbon, Matthew; Sarvothama, Megha; Yechan-Gunja, Sushma; James, Scott E.; Riddell, Stanley R. Share Save
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia Le, Quy; Castro, Sommer; Tang, Thao; Loeb, Anisha M.; Hylkema, Tiffany; McKay, Cyd Nourigat; Perkins, LaKeisha; Srivastava, Shivani; Call, Lindsey; Smith, Jenny; Leonti, Amanda; Ries, Rhonda; Pardo, Laura; Loken, Michael R.; Correnti, Colin; Fiorenza, Salvatore; Turtle, Cameron J.; Riddell, Stanley; Tarlock, Katherine; Meshinchi, Soheil Share Save
Share Save
Share Save
A phase I study of adoptive immunotherapy for ROR1+advanced triple negative breast cancer (TNBC) with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR) Specht, J. M.; Lee, S. M.; Turtle, C.; Berger, C.; Balakrishnan, A.; Srivastava, S.; Viollet, V.; Veatch, J.; Gooley, T.; Mullane, E.; Chaney, C. N.; Rader, C.; Pierce, R. H.; Gottardo, R.; Maloney, D. G.; Riddell, S. R. Share Save
A phase I study of adoptive immunotherapy for advanced ROR1+malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR) Specht, Jennifer M.; Lee, Sylvia; Turtle, Cameron J.; Berger, Carolina; Baladrishnan, Ashwini; Srivastava, Shivani; Voillet, Valentin; Veatch, Josh; Gooley, Ted; Mullane, Erin; Chaney, Colette; Rader, Christoph; Pierce, Robert H.; Gottardo, Raphael; Maloney, David G.; Riddell, Stanley R. Share Save
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia Paszkiewicz, Paulina J.; Fraessle, Simon P.; Srivastava, Shivani; Sommermeyer, Daniel; Hudecek, Michael; Drexler, Ingo; Sadelain, Michel; Liu, Lingfeng; Jensen, Michael C.; Riddell, Stanley R.; Busch, Dirk H. Share Save
Safety of the natural killer (NK) cell-targeted anti-KIR antibody, lirilumab (liri), in combination with nivolumab (nivo) or ipilimumab (ipi) in two phase 1 studies in advanced refractory solid tumors Segal, N. H.; Infante, J. R.; Sanborn, R. E.; Gibney, G. T.; Lawrence, D. P.; Rizvi, N.; Leidner, R.; Gajewski, T. F.; Bertino, E.; Sharfman, W. H.; Cooley, S.; Topalian, S. L.; Urba, W. J.; Wolchok, J. D.; Gu, X.; Passey, C.; McDonald, D.; Aanur, P.; Srivastava, S.; Hodi, F. S. Share Save
Share Save
Share Save
Share Save